Bridgeland, who joined the AIM-listed group in 2015, is succeeding Keith Falconer, who is retiring from the position after over 15 years in the role.
“I am delighted to assume the role of Chair at such an exciting point in Impax’s history. I am very much looking forward to building on Keith’s work alongside my fellow board members to deliver long-term success for the company and create value for all our stakeholders”, Bridgeland said in a statement.
“The commitment of policymakers, business leaders and wider society to forging a path towards a more sustainable economy has never been stronger. Against this backdrop, Impax’s well-established investment philosophy, broad range of investment solutions and acknowledged leadership position will stand the company in good stead to deliver further value to clients over the coming years”, she added.
Impax chief executive Ian Simm said: “I would like to thank Keith for his inspiring leadership, his advice and dedication to Impax during his time as chairman. His business acumen and judgement have greatly contributed to our success, and he will be sorely missed! I am very pleased that Sally is taking over as Impax’s chair. Since she joined the board in 2015, Sally has made a tremendous contribution to the company’s strategic development both as an independent non-executive director and as chair of the audit & risk committee.”
The firm also said it has appointed William Simon O’Regan, former CEO of the US arm of asset manager Mercer, as a non-executive director with effect from December 8.
“This is an exciting time to be joining the Impax board. As the company’s recent results show, Impax is enjoying a very strong period of growth with significant potential to expand further in international markets. I look forward to working with Ian, Sally and the rest of the board to support the next chapter in its story”, O’Regan said.
“On behalf of the board, I’m delighted to welcome Simon O’Regan, who is a highly-experienced investment industry non-executive director and business leader. Simon’s in-depth knowledge of international markets, including the United States, will be invaluable as we continue to develop our business globally”, Simm added.
Impax shares were steady at 720p in early deals on Tuesday.